Q2 2024 · 13F-HR
FCPM III SERVICES B.V.holdings as filed
Filed 2024-08-08 · accession 0001802806-24-000036
$678.1M
Reported value
7
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $276.9M | 40.8% | 7,845,364 | Common | SHARED |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $227.3M | 33.5% | 11,831,461 | Common | SHARED |
| 29286M105 | — | ENGENE HOLDINGS INC | $81.8M | 12.1% | 8,677,951 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $43.8M | 6.46% | 4,866,449 | Common | SHARED |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $43.0M | 6.34% | 2,122,892 | Common | SHARED |
| 29286M113 | — | ENGENE HOLDINGS INC | $3.4M | 0.51% | 2,878,148 | Common | SHARED |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $1.9M | 0.29% | 2,390,050 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.